The London Biotechnology Show is Europe's flagship biopharmaceutical and biotechnology trade event, specifically focusing on "red biotech" and healthcare innovation. This premier exhibition and conference aims to accelerate the progress of biotechnology to revolutionize the global medical and healthcare sector, accentuating advancements in the UK and worldwide. It serves as a crucial platform for leading industry experts, key stakeholders, R&D leaders, and investors from the entire biotechnology value chain. Attendees can explore advancements across biopharmaceuticals, therapeutics, diagnostics, precision medicine, cell and gene therapy, biomanufacturing, and clinical trials. The show provides unparalleled opportunities to connect with innovators, investors, and industry leaders, generate qualified business leads, and stay at the forefront of biotech innovations and enabling technologies. It's an essential event for biotech professionals, executives, and policymakers shaping the future of biotechnology.
Highlights
5 items
01
Europe's Flagship Biotech Event
Positioned as Europe's premier biopharmaceutical and biotechnology trade event, focusing on 'red biotech' and healthcare innovation.
02
Comprehensive Industry Coverage
Explores advancements in biopharmaceuticals, therapeutics, diagnostics, cell/gene therapy, biomanufacturing, and clinical trials.
03
Connect with Biotech Leaders
Gathers industry experts, R&D leaders, investors, policymakers, and startups from the entire biotechnology value chain.
04
Strategic Participation Opportunities
Offers various ways to engage, including stand booking, speaking slots, delegate tickets, and a hosted buyer program.
05
Accelerating Healthcare Innovation
Aims to accelerate biotechnology progress for revolutionizing the global medical and healthcare sector.
Previous Edition
4,000
Attendees
80
Exhibitors
—
Net Area
FAQ
5 questions
The show is scheduled for November 18-19, 2026, at ExCeL London, United Kingdom.
The event targets biotech professionals, executives, R&D leaders, translational scientists, investors, CDMOs, and companies in diagnostics and digital health.
It covers biopharmaceuticals, therapeutics, diagnostics, precision medicine, cell and gene therapy, biomanufacturing, vaccines, and clinical trials.
You can book a stand, apply for speaking, get delegate tickets, or register as a buyer. A Hosted Buyer Programme is also available.
Yes, a 15% MVA member discount and a 'Flat 20% Off on Exhibitor & Sponsorship Packages' were offered for 2026.
